Our findings demonstrated that FMN could alleviate inflammation, apoptosis, and oxidative stress in PCOS models in vivo and in vitro through inhibiting the NLRP3 inflammasome, identifying that FMN holds promise as an effective therapeutic agent for PCOS. Here, NLRP3 is linked to polycystic ovary syndrome.